SecBot SecBot
EFFECT ·Filed Jun 22, 2026

SLXN

Silexion Therapeutics Corp
NEUTRAL
Impact 3/10
Horizonweeks Processed4mo ago SEC9999999995-26-002070
IPO/offering going effective
Actionable Insight • Neutral

Monitor for any subsequent prospectus supplement or takedown announcement. The shelf enables rapid capital access, which could be dilutive given the small market cap. No immediate trading catalyst.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
SLXN ▼ -87.41% at T+60d
NEUTRAL call -87.41% · α vs SPY -89.15% · entry $2.70 → $0.3400
Entry = T+0 close
Jun 22, 2026
via day close
T+1d
+0.37%
call +0.37% · α +1.82%
$2.71
settled 4mo ago
T+5d
+1.85%
call +1.85% · α +3.92%
$2.75
settled 4mo ago
T+20d
-4.44%
call -4.44% · α -4.30%
$2.58
settled 3mo ago
T+60d
-87.41%
call -87.41% · α -89.15%
$0.3400
settled 6w ago

Price Chart

Loading chart...

Executive Summary

Silexion Therapeutics Corp's S-3 shelf registration (File No. 333-296739) became effective on June 18, 2026. This allows the company to offer and sell securities from time to time, creating a potential dilution overhang for the $3M market cap issuer. The effectiveness is a procedural step and does not indicate an immediate offering.

Key Facts

  • S-3 shelf registration (333-296739) declared effective on June 18, 2026.
  • Company has a $3M market cap and is a clinical-stage biotech (SIC 2836).
  • Formerly known as Biomotion Sciences (name change May 2024).
  • No concurrent offering or pricing information provided.

Financial Impact

Potential future dilution; no immediate financial impact from effectiveness alone.

dilution

Risk Factors

  • Future equity offering could significantly dilute existing shareholders.
  • Low market cap makes any offering size potentially material relative to current float.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-002070
Document: 9999999995-26-002070-index.html9999999995-26-002070
Document: 9999999995-26-002070.txt9999999995-26-002070
29 reports for SLXN
Performance horizon
69% Hit rate @ T+20 9 of 13 directional calls Went positive at some point 17 of 19 best @ T+60▲ +90.37%May 26, 2026
Filters
Rows
Reports for SLXN — sortable, filterable
TypeNow
Oct 19, 2026
7d ago
DEFA14A
BEARISH ★ 6/10
$0.1538awaiting T+20—$0.1750 (−13.78%)
Oct 5, 2026
21d ago
DEF 14A
BEARISH ★ 7/10
$0.2628awaiting T+20—$0.1750 (+33.41%)
Sep 30, 2026
26d ago
8-K
BULLISH ★ 6/10
$0.2770awaiting T+20—$0.1750 (−36.82%)
Sep 30, 2026
26d ago
Press Release
BEARISH ★ 7/10
$0.2773awaiting T+20—$0.1750 (+36.89%)
Sep 29, 2026
27d ago
8-K
BEARISH ★ 7/10
$0.3180awaiting T+20—$0.1750 (+44.97%)
Sep 29, 2026
27d ago
Press Release
BEARISH ★ 6/10
$0.3184awaiting T+20—$0.1750 (+45.04%)
Sep 28, 2026
28d ago
8-K
NEUTRAL ★ 4/10
$0.2484 $0.1746▼ −29.71%▼ −29.68%$0.1750 (−29.55%)
Sep 28, 2026
28d ago
Press Release
NEUTRAL ★ 3/10
$0.2484 $0.1746▼ −29.71%▼ −29.68%$0.1750 (−29.55%)
Sep 25, 2026
4w ago
8-K
BEARISH ★ 7/10
$0.2484 $0.1746▲ +29.71%▲ +29.68%$0.1750 (+29.55%)
Aug 14, 2026
10w ago
8-K
BEARISH ★ 6/10
$0.4202 $0.3854▲ +8.28%▲ +6.29%$0.1750 (+58.35%)
Showing 10 of 29

US Market Status

Market Closed — Opens in 8h 14m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 22, 2026